Radio Patrimoine – Journey of a daring woman, Alice Lhabouz

How do you found a management company when you are a woman, young, without connection, without money? This is the challenge taken up by Alice Lhabouz, with audacity and determination. She tells Mathilde Hodouin and Fabrice Cousté how she faced, with the support of her family, this financial environment where there are still too few…

Health sector still plays its cards right

Thanks you Funds Watch for this interview of Alice Lhabouz, CEO and founder of Trecento Asset Management, about the evolution of the healthcare sector on the stock market in the coming months. The manager of the fund Trecento Santé ISR also explained the fund management philosophy, which once again withstands periods of crisis. To read…

Patrimoine24 – Analysis of the COVID-19 crisis (podcast)

On March 27th, 2020, Alice Lhabouz, CEO and founder of Trecento Asset Management, Manager of the fund Trecento Santé ISR, was invited by Patrimoine24 to share her analysis of the COVID-19 crisis and its evolution. “(…) Governments today realize that health has undergone very strong investments under the last few years: we heard Emmanuel Macron…

Challenges – Marriage of convenience between Sanofi and Abbott on diabetes

Christophe Pouchoy, Managing Director and Chief Investment Officer of Trecento Asset Management, co-manager of the Trecento Santé fund, commented in Challenges magazine on the alliance between Sanofi and Abbott announced on September 16th, 2019 – the same day as the one between Novo Nordisk and Medtronic. “Manufacturers are getting closer to medical equipment – sensors,…

Challenges – Voltarene, Nurofen, Doliprane… Why the labs are still running after these drugs

Challenges magazine interviewed Alice Lhabouz, President and Founder of Trecento AM, about the non-prescription drug (“OTC”) market and its recent mergers and acquisitions. “The catalysts for the growth of this market are mainly of a demographic nature: the continuous aging of the world population, the prolongation of the life span, especially in developed countries, (…)”…